TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit


TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit

PR Newswire

ELLICOTT CITY, Md., July 29, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) has announced a new and updated program for the 9th annual Site Solutions Summit, October 10 – 12, 2014 in Amelia Island, Florida.  The focus on collaboration between sponsors, CROs, sites and investigators remains unchanged, however, the topics and format will allow for even more purposeful exchange and networking opportunity among all stakeholders with a continued focus on site sustainability. General session topics will cover factors impacting sites, adaptive solutions around data and recruitment, technology innovation, and operational benchmarks from the SCRS site survey.

Speakers include:

Glen de Vries, President, Medidata Solutions
Kenneth Getz, MBA Director of Sponsored Programs, Tufts, Chairman, CISCRP
Dalvir Gill, PhD Chief Executive Officer, TransCelerate BioPharma
Bill Jordan, VP Clinical Research, Sanofi-Aventis
Jeff Kasher, PhD Vice President, Clinical Innovation and Implementation, Lilly
Jackie Kent, Director, Clinical Development Info & Optimization, Lilly
Craig Lipset, Head of Clinical Innovation,  Pfizer
Susan McHale,  Executive Director, Global Project Delivery, AstraZeneca
Richard A. Moscicki, M.D. Deputy Center Director for Science Operations, FDA
Christine Pierre, President, Society for Clinical Research Sites
Craig Wozniak, Clinical Operations, GSK

"Today, more than ever, all stakeholders feel the intense pressure to perform in unprecedented ways.  The need for collaboration and transformation is now.  The Summit has been and continues to be a catalyst for sites to engage in the dialogue to help create their own sustainability and to adapt to the changing environment," comments Christine Pierre, President of SCRS.  "At the Site Solutions Summit, sites will have the unique opportunity to spend meaningful time with other industry stakeholders – who are all looking for the best partners to navigate their way through the evolution of research development."

About the Site Solutions Summit: The Summit provides a unique platform for dialogue, development, and efficiency improvement across all organizations in the clinical research enterprise.  More than 600 attendees from nearly 100 sponsor/CRO organizations and hundreds of sites and investigators will participate.  Programming will include 10 pre-meeting Master Workshops, more than 40 interactive sessions, and 10 hours of networking events that will include the SCRS Eagle Award, honoring a sponsor and CRO who best exemplifies great site partnerships. 

For more information: www.SiteSolutionsSummit.com and www.mySCRS.org
To visit SCRS Video Channel (Search "mySCRSorg" on YouTube)
Twitter Information: @mySCRS and #scrs14
To register or attend:  denise.davis@myscrs.org 

About SCRS:  SCRS is a global trade organization founded in 2012 and represents over 1,400 research sites, including 13,000 Investigators in 37 countries.  SCRS' mission is to unify and amplify the voice of the global clinical research site community for site sustainability.  SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise.  Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership.  Visit MySCRS.org

SOURCE The Society for Clinical Research Sites (SCRS)

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document

Click here